MARÍA DEL CARMEN
HERNÁNDEZ VALLADARES
CONTRATADA MARÍA ZAMBRANO SENIOR
Publicaciones (48) Publicaciones de MARÍA DEL CARMEN HERNÁNDEZ VALLADARES
2024
2023
-
La proteómica mediante espectrometría de masas como metodología esencial en estudios clínicos
Educación hacia el futuro: enfoque STEAM, ciencias de la salud y deporte (Dykinson), pp. 557-576
-
Mass Spectrometry-Based Proteomics Workflows in Cancer Research: The Relevance of Choosing the Right Steps
Cancers, Vol. 15, Núm. 2
-
Multi-Omic Approaches to Classify, Predict, and Treat Acute Leukemias
Cancers
-
Special Issue “Personal Therapy for Blood Disorders”
Journal of Personalized Medicine
-
Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity
Journal of Clinical Medicine, Vol. 12, Núm. 17
2022
-
A developmental role for the chromatin-regulating CoREST complex in the cnidarian Nematostella vectensis
BMC Biology, Vol. 20, Núm. 1
-
Comparing Efficiency of Lysis Buffer Solutions and Sample Preparation Methods for Liquid Chromatography–Mass Spectrometry Analysis of Human Cells and Plasma
Molecules, Vol. 27, Núm. 11
-
Proteomic approaches for untangling pharmacological targets in acute myelogenous leukemia
Expert Review of Proteomics
2021
-
Effects of the autophagy‐inhibiting agent chloroquine on acute myeloid leukemia cells; characterization of patient heterogeneity
Journal of Personalized Medicine, Vol. 11, Núm. 8
-
Patient Heterogeneity in Acute Myeloid Leukemia: Leukemic Cell Communication by Release of Soluble Mediators and Its Effects on Mesenchymal Stem Cells
DISEASES, Vol. 9, Núm. 4
-
Proteomic comparison of bone marrow derived osteoblasts and mesenchymal stem cells
International Journal of Molecular Sciences, Vol. 22, Núm. 11
-
Proteomic studies of primary acute myeloid leukemia cells derived from patients before and during disease-stabilizing treatment based on all-trans retinoic acid and valproic acid
Cancers, Vol. 13, Núm. 9
-
Therapeutic use of valproic acid and all-trans retinoic acid in acute myeloid leukemia—literature review and discussion of possible use in relapse after allogeneic stem cell transplantation
Pharmaceuticals, Vol. 14, Núm. 5
2020
-
Biological characteristics of aging in human acute myeloid leukemia cells: the possible importance of aldehyde dehydrogenase, the cytoskeleton and altered transcriptional regulation
Aging, Vol. 12, Núm. 24, pp. 24734-24777
-
Proteome and phosphoproteome changes associated with prognosis in acute myeloid leukemia
Cancers, Vol. 12, Núm. 3
-
The implementation of mass spectrometry-based proteomics workflows in clinical routines of acute myeloid leukemia: Applicability and perspectives
International Journal of Molecular Sciences, Vol. 21, Núm. 18, pp. 1-23
-
The progression of acute myeloid leukemia from first diagnosis to chemoresistant relapse: A comparison of proteomic and phosphoproteomic profiles
Cancers, Vol. 12, Núm. 6, pp. 1-13
2019
-
Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cells
Signal Transduction and Targeted Therapy, Vol. 4, Núm. 1
-
Protein post-translational modification crosstalk in acute myeloid leukemia calls for action
Current Medicinal Chemistry, Vol. 26, Núm. 28, pp. 5317-5337